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Deletion of a conserved Gata2 enhancer impairs
haemogenic endothelium programming and adult
Zebraﬁsh haematopoiesis
Tomasz Dobrzycki1, Christopher B. Mahony2, Monika Krecsmarik1,3, Cansu Koyunlar4, Rossella Rispoli1,5,
Joke Peulen-Zink 4, Kirsten Gussinklo4, Bakhta Fedlaoui2, Emma de Pater 4, Roger Patient1,3 &
Rui Monteiro 1,2,3✉
Gata2 is a key transcription factor required to generate Haematopoietic Stem and Pro-
genitor Cells (HSPCs) from haemogenic endothelium (HE); misexpression of Gata2 leads to
haematopoietic disorders. Here we deleted a conserved enhancer (i4 enhancer) driving
pan-endothelial expression of the zebraﬁsh gata2a and showed that Gata2a is required for
HE programming by regulating expression of runx1 and of the second Gata2 orthologue,
gata2b. By 5 days, homozygous gata2aΔi4/Δi4 larvae showed normal numbers of HSPCs, a
recovery mediated by Notch signalling driving gata2b and runx1 expression in HE.
However, gata2aΔi4/Δi4 adults showed oedema, susceptibility to infections and marrow
hypo-cellularity, consistent with bone marrow failure found in GATA2 deﬁciency
syndromes. Thus, gata2a expression driven by the i4 enhancer is required for correct HE
programming in embryos and maintenance of steady-state haematopoietic stem cell output
in the adult. These enhancer mutants will be useful in exploring further the pathophysiology
of GATA2-related deﬁciencies in vivo.
https://doi.org/10.1038/s42003-020-0798-3 OPEN
1MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK.
2 Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK. 3 BHF Centre of
Research Excellence, Oxford, UK. 4 Department of Hematology, Erasmus MC, Rotterdam, The Netherlands. 5 Division of Genetics and Molecular Medicine,
NIHR Biomedical Research Centre, Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK. ✉email: r.monteiro@bham.ac.uk
COMMUNICATIONS BIOLOGY |            (2020) 3:71 | https://doi.org/10.1038/s42003-020-0798-3 |www.nature.com/commsbio 1
12
34
56
78
9
0
()
:,;
Haematopoietic stem cells (HSCs) are the source of allblood produced throughout the lifetime of an organism.They are capable of self-renewal and differentiation into
progenitor cells that generate specialised blood cell types. DNA-
binding transcription factors are fundamental players in the
inception of the haematopoietic system as it develops in the
embryo, but also play a crucial role in maintaining homeostasis of
the haematopoietic system in the adult organism. They coordi-
nate differentiation, proliferation and survival of haematopoietic
cells and ensure their levels are appropriate at all times
throughout life. Misexpression of key transcription factors may
thus lead to a failure to produce HSCs or, alternatively, to hae-
matopoietic disorders and eventually leukaemia. Therefore,
understanding how transcription factors drive the haematopoietic
process provides opportunities for intervention when haemato-
poiesis is dysregulated.
The development of blood occurs in distinct waves: primitive,
pro-deﬁnitive and deﬁnitive, each of them characterised by the
generation of blood progenitors in a speciﬁc location and
restricted in time, where the deﬁnitive wave produces multi-
lineage self-renewing HSCs1. The speciﬁcation of HSCs initiates
in cells with arterial characteristics2 and proceeds through an
endothelial intermediate, termed the haemogenic endothelium
(HE)3. In zebraﬁsh and other vertebrates, expression of runx1
deﬁnes the bona ﬁde HE population4,5. Haematopoietic stem and
progenitor cells (HSPCs) emerge from the HE by endothelial-
to-haematopoietic transition (EHT), both in zebraﬁsh and in
mice6–8. They arise between 28 and 48 h post fertilisation (hpf)
from the HE in the ventral wall of the dorsal aorta (DA)9, the
analogue of the mammalian aorta-gonad-mesonephros (AGM)10.
After EHT, the HSCs enter the bloodstream through the posterior
cardinal vein (PCV)9 to colonise the caudal haematopoietic tissue
(CHT), the zebraﬁsh equivalent of the mammalian foetal liver11.
Afterwards the HSCs migrate again within the bloodstream to
colonise the kidney marrow (WKM) and thymus9, the ﬁnal niche
for HSCs, equivalent to the bone marrow in mammals1.
Gata2 is a key haematopoietic transcription factor (TF) in
development. In humans, GATA2 haploinsufﬁciency leads to
blood disorders, including MonoMAC syndrome (Mono-
cytopenia, Mycobacterium avium complex) and myelodysplastic
syndrome (MDS)12,13. While its presentation is variable, Mono-
MAC syndrome patients always show cytopenias, ranging from
mild to severe, and hypocellular bone marrow13,14. These patients
are susceptible to mycobacterial and viral infections, and have a
propensity to develop MDS and Acute Myeloid Leukaemia
(AML), with a 75% prevalence and relatively early onset at age
2013.
Gata2 knockout mice are embryonic lethal and die by E10.515.
Conditional Gata2 knockout under the control of the endothelial
VE-cad promoter abolished the generation of intra-aortic clus-
ters16, suggesting that Gata2 is required for HSPC formation.
Further studies in the mouse revealed a decrease in HSC numbers
in Gata2 heterozygous mutants, but also a dose-dependency of
adult HSCs on Gata217.
Gata2 expression in the endothelium is regulated by an
intronic enhancer element termed the +9.5 enhancer18,19. Dele-
tion of this enhancer results in the loss of HSPC emergence from
HE, leading to lethality by E1419. The same element is also
mutated in 10% of all the MonoMAC syndrome patients12.
Because of a partial genome duplication during the evolution of
teleost ﬁsh, numerous zebraﬁsh genes exist in the form of two
paralogues, including gata220. This provides an opportunity to
separately identify the temporally distinct contributions made by
each Gata2 orthologue. Gata2a and gata2b are only 57% identical
and are thought to have undergone evolutionary sub-
functionalisation from the ancestral vertebrate Gata2 gene21,22.
Gata2b is expressed in HE from 18hpf and is thought to regulate
runx1 expression in HE21. Lineage tracing experiments showed
that gata2b-expressing HE cells gave rise to HSCs in the adult21.
Similar to the mouse Gata2, gata2b expression depends on Notch
signalling and is a bona ﬁde marker of HE, currently regarded as
the functional ‘haematopoietic homologue’ of Gata2 in zebra-
ﬁsh21. By contrast, gata2a is expressed in all endothelial cells and
in the developing central nervous system21,23. Homozygous
gata2aum27 mutants showed arteriovenous shunts in the dorsal
aorta at 48hpf24. However, gata2a is expressed at 11hpf in the
haemangioblast population in the posterior lateral mesoderm
(PLM) that gives rise to the arterial endothelial cells in the
trunk25, well before gata2b is expressed in HE. This suggests that
gata2a might play a role in endothelial and HE programming and
thus help to elucidate an earlier role for Gata2 in HSC
development.
Here we show that the gata2a locus contains a conserved
enhancer in its 4th intron, corresponding to the described +9.5
enhancer in the mouse Gata2 locus18,19. Using CRISPR/Cas9
genome editing, we demonstrated that this region, termed the i4
enhancer, is required for endothelial-speciﬁc gata2a expression.
Homozygous mutants (gata2aΔi4/Δi4 mutants) showed decreased
expression of the HE-speciﬁc genes runx1 and gata2b. Thus,
endothelial expression of gata2a, regulated by the i4 enhancer, is
required for gata2b and runx1 expression in the HE. Strikingly,
their expression recovers and by 48hpf, the expression of hae-
matopoietic markers in gata2aΔi4/Δi4 mutants is indistinguishable
from wild-type siblings. We have demonstrated that this recovery
is mediated by an independent input from Notch signalling,
sufﬁcient to recover gata2b and runx1 expression in HE and thus
HSPC emergence by 48hpf. We conclude that runx1 and gata2b
are regulated by two different inputs, one Notch-independent
input from Gata2a and a second from the Notch pathway, acting
as a fail-safe mechanism for the initial speciﬁcation of HSPCs in
the absence of the input by Gata2a. Despite the early rescue,
gata2aΔi4/Δi4 adults showed increased susceptibility to infections,
oedema, a hypocellular WKM and neutropenia, a phenotype
resembling key features of GATA2 deﬁciency syndromes in
humans. We conclude that Gata2a is required for HE program-
ming in the embryo and to maintain the steady-state haemato-
poietic output from adult HSPCs and that this function requires
the activity of the i4 enhancer.
Results
Analysis of open chromatin regions in the gata2a locus.
Because Gata2 genes are duplicated in zebraﬁsh, we set out to
unpick the different roles Gata2a and Gata2b play during HSC
generation and homeostasis by identifying their regulatory
regions. Analysis of sequence conservation revealed that one
region within the fourth intron of the zebraﬁsh gata2a locus was
conserved in vertebrates, including mouse and human (Fig. 1a–c).
This region, which we termed ‘i4 enhancer’, corresponds to the
endothelial +9.5 Gata2 enhancer identiﬁed previously in the
mouse18,19 and human26. Notably, the gata2b locus did not show
broad conservation in non-coding regions (Supplementary
Fig. 1a).
To investigate whether the i4 element was a potentially active
enhancer, we ﬁrst performed ATAC-seq27 to identify open
chromatin regions in endothelial cells (ECs) in zebraﬁsh. We used
a Tg(kdrl:GFP) transgenic line that expresses GFP in all
endothelium28 and isolated the higher GFP-expressing ECs
(kdrl:GFPhigh, termed kdrl:GFP+ for simplicity) as this fraction
was enriched for endothelial markers compared to the kdrl:
GFPlow fraction (Supplementary Fig. 1b, c). Principal Component
Analysis on the ATAC-seq data from 26hpf kdrl:GFP+ cells
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Fig. 1 The i4 enhancer in the gata2a locus is conserved and drives pan-endothelial expression of a GFP reporter in zebraﬁsh. a Kdrl:GFP+ (green) and
kdrl:GFP− (blue) cells were FACS-sorted from 26hpf embryos and used for preparation of ATAC-seq libraries. b The image of the mapped reads represents
stacked means of two biological ATAC-seq replicates. Differential peak analysis identiﬁed four chromatin regions (blue shading) in the locus of gata2a that
are signiﬁcantly more open in the kdrl:GFP+ population (p < 0.0001). A region in the fourth intron (termed i4 enhancer) is conserved throughout
vertebrates. Black and grey shading denotes regions of high conservation between the species analysed. c The highly conserved 150 bp region (red)
contains putative transcription factor binding sites, mapped computationally. Light blue: Ets binding sites; purple: E-box binding sites; green: GATA binding
sites; asterisks: conserved residues. d Wideﬁeld ﬂuorescent image of a live Tg(gata2a-i4-1.1 kb:GFP) zebraﬁsh embryo at 27hpf showing GFP ﬂuorescence
in the endothelial cells and in the heart (endocardium). e Higher magniﬁcation image of the trunk of the embryo from panel d. f–f″ Confocal images of a
trunk fragment of a Tg(gata2a-i4-1.1 kb:GFP) embryo immunostained with anti-GFP antibody (f) and probed for gfp mRNA (f′) at 25hpf. f″ Merged images
from panels f–f′ with Hoechst nuclear staining in blue, showing complete overlap of GFP protein and mRNA. g–g″ Confocal images of the dorsal aorta (DA)
and posterior cardinal vein (PCV) of a Tg(gata2a-i4-1.1 kb:GFP) embryo immunostained with anti-GFP antibody (g) and probed for runx1 mRNA (g′) at
25hpf. See panel e for approximate position within the embryo. g″ Merged images from panels g–g’, also showing Hoechst nuclear staining in blue.
h Counting of the runx1+ cells represented in panels g′–g″ in 25 embryos shows that >90% of runx1+ cells are also GFP+. N= 3. Error bars: ± SD. See also
Supplementary Fig. 1.
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(n= 2) and kdrl:GFP− cells (n= 4) revealed strong differences
between the open chromatin regions in the two cell populations,
further supported by a correlation analysis (Supplementary
Fig. 1d–f). 78,026 peaks were found in common between
replicates of the ATACseq in kdrl:GFP+ cells (Supplementary
Fig. 1g). 44,025 peaks were differentially expressed between the
kdrl:GFP+ and kdrl:GFP− fractions (Supplementary Fig. 1h). An
analysis of known motifs present in the kdrl:GFP+ population
revealed an enrichment for the ETS motif (Supplementary
Fig. 1i). ETS factors are essential regulators of gene expression
in endothelium29. In addition, we performed gene ontology (GO)
term analysis on the peaks showing >3-fold enrichment or
depletion in ECs (Supplementary Fig. 1j–l). As expected, non-ECs
showed a broad range of GO terms whereas EC-enriched peaks
were associated with terms like angiogenesis or blood vessel
development (Supplementary Fig. 1k, l).
Differential peak analysis in the gata2a locus identiﬁed four
differentially open sites within a 20 kb genomic region (Fig. 1b),
including one peak in intron 4 corresponding to the predicted i4
enhancer. It contained a core 150 bp-long element that included
several binding motifs for the GATA, E-box and Ets transcription
factor families (Fig. 1b). Although the positioning of the E-box
site relative to the adjacent GATA site differs in zebraﬁsh and
mammals (Fig. 1b, c), the necessary spacer distance of ~9 bp
between the two sites30 was conserved. Thus, this site may be a
target for TF complexes containing an E-box-binding factor and a
GATA family TF.
Thus, the intronic enhancer (i4) identiﬁed in the zebraﬁsh
gata2a locus is accessible to transposase in endothelial cells and
contains highly conserved binding sites for key haematopoietic
transcription factors, suggesting that genetic regulation of gata2a
expression in zebraﬁsh HE is a conserved feature of vertebrate
gata2 genes.
The gata2a-i4 enhancer drives GFP expression in endothelium.
To investigate the activity of the gata2a-i4 enhancer in vivo, the
conserved genomic 150 bp region (Fig. 1b, c), together with
ﬂanking ±500 bp (gata2a-i4-1.1 kb:GFP) or ±150 bp (gata2a-i4-
450 bp:GFP) was cloned into a Tol2-based reporter E1b:GFP
construct31 and used to generate stable transgenic lines (Sup-
plementary Fig. 2). The earliest activity of the enhancer was
observed at the 14-somite stage (14ss), when gfp mRNA was
detected in the PLM (Supplementary Fig. 2a, b). After 22hpf, the
reporter signal was pan-endothelial (Fig. 1d–e, Supplementary
Fig. 2c–i). Around 27hpf, higher intensities of GFP ﬂuorescence
and correspondingly higher levels of gfp mRNA were visible in
the ﬂoor of the DA (Fig. 1d–e, Supplementary Fig. 2e–h). While
the GFP protein was still visible in the vasculature around 3dpf, it
was likely carried over from earlier stages, since the gfp mRNA
was not detectable any more (Supplementary Fig. 2i, j). We
focussed our subsequent analysis on the gata2a-i4-1.1 kb:GFP
transgenics as they showed stronger expression of the transgene.
At 25hpf, the expression of GFP protein and gfp mRNA over-
lapped completely in the endothelial cells of the DA (Fig. 1f–f″).
Overall, these data conﬁrm that the i4 enhancer is active in vivo
in endothelial cells at the correct time to regulate deﬁnitive
haematopoiesis. The endothelial activity of the corresponding
+9.5 enhancer was also observed in mouse embryos18, indicating
functional conservation of the gata2a-i4 enhancer across
vertebrates.
To further characterise the enhancer activity in vivo, Tg
(gata2a-i4-1.1 kb:GFP) embryos were stained for gata2a mRNA
and for GFP protein (Supplementary Fig. 2k–o). We found a large
overlap between gata2a+ and GFP+ cells at 30hpf in the DA, with
a small proportion of GFP+ cells that did not express gata2a
mRNA (<5%, Supplementary Fig. 2o). This could suggest that
some cells require activity of other endothelial enhancers to
trigger transcription of gata2a or that gfp mRNA has a longer
half-life than gata2a mRNA. Importantly, the GFP signal was
absent in gata2a-expressing neural cells (Supplementary
Fig. 2l–n), indicating that the i4 enhancer is speciﬁcally active
in (haemogenic) endothelial cells.
Next we examined the expression of the HE marker runx14 in
gata2a-i4-1.1 kb:GFP embryos at 25hpf. At this stage, over 90% of
runx1+ cells were GFP+ (Fig. 1g–h). We conclude that the GFP
expression under the gata2a-i4 enhancer marks the majority of
the HE population.
Endothelial gata2a required gata2a-i4 enhancer activity. To
investigate whether endothelial-speciﬁc expression of gata2a is
required for deﬁnitive haematopoiesis, we deleted the conserved
gata2a-i4 enhancer using CRISPR/Cas9 genome editing32. We
generated a deletion mutant lacking 231 bp of the i4 enhancer
(Supplementary Fig. 3a–c) and named it gata2aΔi4/Δi4. Homo-
zygous gata2aΔi4/Δi4 mutants showed decreased levels of gata2a
expression in endothelial cells when compared to wild-type
embryos (Fig. 2a, b). By contrast, gata2a expression in the neural
tube appeared unaffected in the gata2aΔi4/Δi4 mutants (Fig. 2a, b).
At 28hpf, expression of the pan-endothelial marker kdrl was
indistinguishable between wild-type and gata2aΔi4/Δi4 mutants
(Fig. 2c, d). To verify these results, we crossed homozygous
gata2aΔi4/Δi4 mutants to Tg(kdrl:GFP) transgenics and analysed
vascular morphology. Gata2aΔi4/Δi4 embryos showed no gross
vascular abnormalities at 48hpf as assessed by the expression of
the Tg(kdrl:GFP) transgene (Fig. 2e, f).
Next, we isolated endothelial cells from Tg(kdrl:GFP) and
Tg(kdrl:GFP); gata2aΔi4/Δi4 embryos by FACS (Fig. 2g) at 23hpf
and 30hpf and conﬁrmed by qRT-PCR that the endothelial
markers kdrl, dld and dll4 were unaffected in gata2aΔi4/Δi4
embryos (Supplementary Fig. 3d–f). The arterial marker efnb2a33
was decreased at 23hpf in gata2aΔi4/Δi4 mutants but recovered by
30hpf (Supplementary Fig. 3g). In addition, gata2a was
signiﬁcantly decreased in the kdrl:GFP+ ECs in 23hpf
gata2aΔi4/Δi4 embryos compared to wild types (Fig. 2h). At
30hpf this decrease was not statistically signiﬁcant. This was likely
due to a decrease in expression of gata2a that appears to occur in
wild-type ECs during development, whereas gata2a expression in
mutants remained low (Fig. 2h). Importantly, there was no
difference in gata2a expression in the non-endothelial population
(kdrl:GFP− cells) between wild-type and gata2aΔi4/Δi4 mutants at
either 23 hpf or 30hpf (Fig. 2i). Altogether, these data suggest that
genomic deletion of the gata2a-i4 enhancer is sufﬁcient to reduce
expression of gata2a speciﬁcally in endothelium.
Gata2a regulates runx1 and gata2b in haemogenic endothe-
lium. To investigate a potential role of gata2a in HSC develop-
ment, we compared the expression of runx1, the key marker of
HE in zebraﬁsh4, in wild-type and gata2aΔi4/Δi4 embryos.
Quantitative in situ hybridization (ISH) analysis34 showed that
runx1 expression was decreased in gata2aΔi4/Δi4 embryos at 24hpf
(Supplementary Fig. 4a–c) and 28hpf compared to wild-type
siblings (Fig. 3a–c). Further analysis in kdrl:GFP+ ECs showed
that this decrease in runx1 expression was already detectable at
23hpf in gata2aΔi4/Δi4 mutants (Fig. 3d), at the onset of its
expression in HE35. Thus, deletion of the gata2a-i4 enhancer
results in impaired runx1 expression in the early stages of HE
programming. This correlates well with decreased runx1 expres-
sion levels in +9.5−/− mouse AGM explants19, further support-
ing the critical evolutionary role of the intronic enhancer of Gata2
in HSC speciﬁcation.
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Next, we tested whether Gata2a could act upstream of gata2b
by measuring its expression in gata2aΔi4/Δi4 embryos. Quantita-
tion of the ISH signal showed that gata2b expression was
decreased in gata2aΔi4/Δi4 embryos compared to wild-type
siblings at 26hpf (Supplementary Fig. 4d) and 28hpf (Fig. 3e–g),
but recovered to wild-type levels by 30hpf (Supplementary
Fig. 4e). Accordingly, kdrl:GFP+; gata2aΔi4/Δi4 cells express
signiﬁcantly lower levels of gata2b mRNA than the wild-type
kdrl:GFP+ endothelial population at 23hpf, but not at 30hpf
(Fig. 3h). These data suggest that endothelial expression of gata2a
Fig. 2 Deletion of the i4 enhancer in gata2aΔi4/Δi4 mutants leads to reduced levels of gata2a mRNA in the endothelium. a, b A signiﬁcant majority of
gata2aΔi4/Δi4 mutants have reduced levels of gata2a mRNA in the dorsal aorta (arrows) at 28hpf, compared to wild-type siblings, as detected with in situ
hybridization. (Χ2= 10.720, d.f.= 1, p < 0.01). The expression in the neural tube appears unaffected. c, d In situ hybridization for the endothelial marker kdrl
at 28hpf reveals no difference between gata2aΔi4/Δi4 mutants and wild-type siblings. The dorsal aorta (arrows) appears unaffected. e, f Live images of the
trunks of 48hpf Tg(kdrl:GFP) and Tg(kdrl:GFP); gata2aΔi4/Δi4 embryos show normal vascular morphology in the mutants. The endothelium of the dorsal
aorta (arrows) appears normal in the gata2aΔi4/Δi4 embryos. g Kdrl:GFPhigh and kdrl:GFP− cells were sorted from non-mutant (WT, blue) and gata2aΔi4/Δi4
(red) embryos carrying the Tg(kdrl:GFP) transgene. h, i qRT-PCR on RNA isolated from the sorted kdrl:GFPhigh or kdrl:GFP- cells (panel g) shows decreased
levels of gata2a mRNA in the endothelium of gata2aΔi4/Δi4 mutants at 23hpf (t= 20.026,d.f.= 5, p < 0.001) compared to wild-type. At 30hpf this
difference is not statistically signiﬁcant (t= 2.146, d.f.= 4, p= 0.098). There is no difference in gata2a mRNA levels in non-endothelial cells between wild-
type and gata2aΔi4/Δi4 mutants (23hpf: t= 0.69, d.f.= 5, p > 0.5; 30hpf: t= 0.618, d.f.= 4, p > 0.5). N= 4 for gata2aΔi4/Δi4 at 23hpf, N= 3 for other
samples. Note different scales of expression levels. ***p < 0.001. See also Supplementary Fig. 2.
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is required upstream of gata2b and runx1 for the proper
speciﬁcation of HE, uncovering a previously unrecognized role
for Gata2a in deﬁnitive haematopoiesis.
Recovery of embryonic HSC activity in gata2aΔi4/Δi4 mutants.
The qPCR analysis in sorted kdrl:GFP+; gata2aΔi4/Δi4 and wild-
type kdrl:GFP+ ECs (Fig. 3d) already suggested a recovery of runx1
expression from 30hpf. Of note, the kdrl:GFP+ population likely
includes the kdrl+, runx1-expressing erythromyeloid progenitors
(EMPs) located in the caudal region36. This region was not included
in the quantiﬁcation of ISH but cannot be separated by sorting for
kdrl:GFP+ and could thus explain the discrepancy between image
Fig. 3 Loss of gata2a expression in the endothelium of gata2aΔi4/Δi4 mutants leads to decreased levels of runx1 and gata2b in the HE. a, b In situ
hybridization for runx1 expression in the HE of wild-type and gata2aΔi4/Δi4 embryos at 28hpf. c Quantiﬁcation of the runx1 in situ hybridization signal from
wild-type (blue), heterozygous gata2a+/Δi4 (het, yellow) and gata2aΔi4/Δi4 (red) siblings at 28hpf shows signiﬁcant decrease in runx1 pixel intensity in the
DA in the homozygous mutants compared to wild-type (µwt= 34.8, µmut= 25.3; F= 4.956, d.f.= 2, 58; ANOVA),**p < 0.01. n= 14, wild-type; n= 25, het;
n= 23, gata2aΔi4/Δi4. Error bars: mean ± SD. d qRT-PCR on RNA isolated from the sorted kdrl:GFP+ cells shows decreased levels of runx1 mRNA in the
endothelium of gata2aΔi4/Δi4 mutants at 23hpf (t= 2.585, d.f.= 5, p < 0.05) but not at 30hpf (t= 1.326, d.f.= 4, p > 0.2), compared to wild-type. N= 4 for
gata2aΔi4/Δi4 at 23hpf, N= 3 for other samples. Note different scales of expression levels. *p < 0.05. e, f Gata2b expression in the HE of wild-type
and gata2aΔi4/Δi4 embryos at 28hpf. g Quantiﬁcation of the gata2b mRNA signal, detected by in situ hybridization, from wild-type (blue), heterozygous
gata2a+/Δi4 (het; yellow) and gata2aΔi4/Δi4 (red) siblings at 28hpf shows signiﬁcant decrease in gata2b pixel intensity in the DA in the homozygous
mutants compared to wild-type (µwt= 39, µmut= 30.1; F= 5.05, d.f.= 2, 54; ANOVA), *p < 0.05. n= 22, wild-type; n= 24, het; n= 11, gata2aΔi4/Δi4. Error
bars: mean ± SD. h qRT-PCR in sorted kdrl:GFP+ cells showed decreased levels of gata2b mRNA in the endothelium of gata2aΔi4/Δi4 mutants at 23hpf (t=
3.334, d.f.= 5, p < 0.05) but not at 30hpf (t= 0.373, d.f.= 4, p > 0.7), compared to wild-type. N= 4 for gata2aΔi4/Δi4 at 23hpf, N= 3 for other samples.
*p < 0.05. See also Supplementary Figs. 3 and 4.
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quantiﬁcation and qRT-PCR. To further characterize the haemato-
poietic phenotype in the gata2aΔi4/Δi4 mutants, we tested whether
expression of markers of haematopoietic activity in the embryo was
affected from 48hpf onwards (Fig. 4).
At 48hpf, the expression of runx1 in the DA showed no
signiﬁcant difference between gata2aΔi4/Δi4 mutants and wild-
type controls (Fig. 4a, b). These data suggest that the decrease
of runx1 expression at early stages of HE programming in
gata2aΔi4/Δi4 mutants is transient and recovers by 2dpf. Indeed,
analysis of the HSPC marker cmyb11 in the CHT at 4dpf showed
no differences between gata2aΔi4/Δi4 and wild-type larvae
(Fig. 4c, d). Expression of the T-cell progenitor marker rag1 in
the thymus37 showed that around half of the gata2aΔi4/Δi4 larvae
had reduced rag1 expression at 4dpf compared to wild-type
(Fig. 4e, f). This effect was absent at 5dpf (Fig. 4g, h), suggesting
that HSPC activity was normal in gata2aΔi4/Δi4 mutants from
4dpf onwards. Next, we crossed the gata2aΔi4/Δi4 mutants to Tg
(itga2b:GFP) transgenics, where itga2b-GFPhigh and itga2b-
GFPlow cells in the CHT mark thrombocytes and HSPCs,
respectively9,38. Our analysis revealed no difference in itga2b-
GFPlow HSPC or itga2b-GFPhigh thrombocyte numbers in the
CHT region at 5dpf between wild-type and gata2aΔi4/Δi4 mutants
(Fig.4i–l). Taken together, our data suggest that endothelial
gata2a expression mediated by the i4 enhancer is required for the
initial expression of gata2b and runx1 in the HE but largely
dispensable after 2dpf.
Notch recovers haematopoiesis in gata2aΔi4/Δi4 mutants. The
recovery of gata2b expression by 30hpf (Fig. 3h, Supplementary
Fig. 4e) coincides temporally with the observed decrease in gata2a
in wild-type endothelial cells (Fig. 2h). Thus, we reasoned that
other regulators of gata2b might compensate for the lack of
endothelial gata2a in gata2aΔi4/Δi4 mutants and thus lead to a
recovery of the initial haematopoietic phenotype. Therefore, we
Fig. 4 Gata2aΔi4/Δi4 mutants display a recovery of the initial haematopoietic defects from 48hpf. a Representative image of runx1 expression in the
trunk of a wild-type embryo at 48hpf showing runx1 mRNA in the dorsal aorta (arrow). b Quantiﬁcation of the runx1 in situ hybridization signal in wild-type
(blue) and gata2aΔi4/Δi4 mutants (red) siblings at 48hpf. There is no signiﬁcant difference in runx1 pixel intensity in the DA between the homozygous
mutants and wild-type (µwt= 33.1, µmut= 37.5, t= 1.410, d.f.= 44, p= 0.17. n= 19, wild-type; n= 27, gata2aΔi4/Δi4). Error bars: mean ± SD. c, d In situ
hybridization for cmyb in the CHT. We detected no difference in expression between wild-type and gata2aΔi4/Δi4 siblings at 4dpf. (e–h) In situ
hybridization (ventral view) for rag1 in the thymii, showing a slight decrease (relative to wild-type) in rag1 (red arrows) in approximately half of the
homozygous mutant embryos at 4dpf. This effect is absent at 5dpf. (i, j) Maximum projections of itga2b:GFP transgenic embryos in the CHT at 5dpf in
i wild-type and j gata2aΔi4/Δi4 siblings. k HSPC (itga2b:GFPlow) counts in the CHT of wild-type (n= 10) and gata2aΔi4/Δi4 mutants (n= 12) at 5dpf. No
difference was detected between genotypes (μwt= 153.5; μmut= 145.5; p= 0.98, Mann-Whitney test). l Thrombocyte (itga2b:GFPhigh) counts in the CHT
of wild-type (n= 10) and gata2aΔi4/Δi4 mutants (n= 12) at 5dpf. No difference was detected between genotypes (μwt= 13; μmut= 13; p= 0.71, Mann-
Whitney test). Error bars: median ± SD.
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investigated whether the loss of gata2b in gata2aΔi4/Δi4 back-
ground resulted in a more severe haematopoietic phenotype than
observed in the gata2aΔi4/Δi4 mutants. For this, we injected
gata2aΔi4/Δi4 and wild-type controls with a suboptimal amount
(7.5 ng) of a gata2b morpholino oligonucleotide (MO)21. Quan-
titative ISH analysis conﬁrmed that this amount of gata2b MO
had no effect on runx1 expression at 32hpf (Fig. 5a, b). As
expected, runx1 expression in gata2aΔi4/Δi4 embryos was sig-
niﬁcantly reduced compared to wild-type siblings (Fig. 5a, b).
Gata2b knockdown in gata2aΔi4/Δi4 embryos further reduced
runx1 expression (Fig. 5a, b). To test whether this stronger
reduction of runx1 at 32hpf affected later stages of embryonic
haematopoiesis, we assessed cmyb expression in the CHT at 4dpf
(Fig. 5c). We scored cmyb expression levels as ‘wild-type’ or
‘reduced’ and found that the ‘reduced’ embryos were substantially
overrepresented in the gata2aΔi4/Δi4 mutants injected with the
gata2b MO, compared to wild-type ﬁsh and non-injected
gata2aΔi4/Δi4 siblings (Fig. 5c).
To verify whether Gata2b is required for deﬁnitive haematopoi-
esis downstream of Gata2a, we generated a frameshift truncating
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mutant for Gata2b and incrossed gata2aΔi4/+; gata2b+/− adults to
investigate cmyb expression at 33hpf in their progeny. Gata2b−/−
mutants showed a more severe decrease in cmyb expression
than gata2aΔi4/Δi4mutants (Supplementary Fig. 4f–i). Double
gata2b−/−; gata2aΔi4/Δi4 mutants showed no further reduction
in cmyb expression compared to gata2b−/− mutants, suggesting
that Gata2a was not sufﬁcient to drive cmyb expression in HE in
the absence of Gata2b (Supplementary Fig. 4f–i). Taken together,
we conclude that Gata2b is regulated by Gata2a and is required for
deﬁnitive haematopoiesis.
Next, we tested whether forced ectopic expression of gata2b
was sufﬁcient to speed up the haematopoietic recovery of
gata2aΔi4/Δi4 embryos. Thus, we overexpressed gata2b under
the control of the gata2a-i4-450bp enhancer in wild-type and
gata2aΔi4/Δi4 mutant embryos and measured runx1 expression at
28hpf in the DA. Gata2aΔi4/Δi4 embryos showed a signiﬁcant
decrease in runx1 expression in comparison to wild-type (Fig. 5d).
Ectopic expression of gata2b under the gata2a-i4 enhancer
signiﬁcantly increased runx1 expression in wild-type and mutants
(Fig. 5d). Importantly, it was sufﬁcient to bring the runx1
expression levels in the mutants up to the levels detected in
uninjected wild-type embryos (Fig. 5d), demonstrating that
gata2b alone was sufﬁcient to drive runx1 expression and drive
the haematopoietic recovery in gata2aΔi4/Δi4 mutants. Thus,
gata2b can recover the deﬁnitive haematopoietic programme in
the absence of endothelial gata2a.
Because the expression of gata2b is regulated by Notch
signalling21, we investigated whether inhibition of Notch would
also prevent the haematopoietic recovery of gata2aΔi4/Δi4
embryos. For this, we used the Notch inhibitor DAPM39, and
titrated it down to a suboptimal dose (25 μM) that did not
signiﬁcantly affect runx1 expression at 30hpf in wild-type
embryos (Supplementary Fig. 5a). This dose induced a small
but measurable decrease in gata2b expression in DAPM-treated
embryos while higher doses had a more robust effect (Supple-
mentary Fig. 5b). Next, we treated wild-type and gata2aΔi4/Δi4
mutant embryos with DAPM and measured runx1 expression in
the DA at 36hpf (Fig. 5e, f). Suboptimal DAPM treatment did not
affect runx1 expression in wild-type embryos (Fig. 5e, f), but
gata2aΔi4/Δi4 mutants showed lower runx1 levels and DAPM
treatment further reduced runx1 expression (Fig. 5e, f). Treat-
ment with 25 μM DAPM did not signiﬁcantly affect gata2b
expression at 36hpf in either wild-type or gata2aΔi4/Δi4 mutant
embryos (Supplementary Fig. 5c). These experiments suggested
that Notch signalling alone may be sufﬁcient to rescue expression
of HE markers in gata2aΔi4/Δi4 mutants. Indeed, ectopic
activation of Notch signalling in endothelium using a ﬂi1a-
NICD:GFP construct40 led to increased runx1 and gata2b
expression in wild-type embryos (Supplementary Fig. 5d, e).
When overexpressed in gata2aΔi4/Δi4 mutants, ﬂi1a-NICD:GFP
rescued runx1 expression to near wild-type levels at 26hpf,
whereas gata2b was increased beyond normal levels indepen-
dently of the genotype (Supplementary Fig. 5f, g). Taken together,
these experiments conﬁrm that Notch activity regulates runx1
and gata2b in HE and is sufﬁcient to drive haematopoietic
recovery in gata2aΔi4/Δi4 mutants. Thus, we conclude that HE
programming requires two independent inputs on runx1 and
gata2b expression; one from Gata2a, driven in ECs by the i4
enhancer, and the other from Notch signalling, necessary and
sufﬁcient to drive HE programming even in the absence of
gata2a.
Impaired haematopoiesis in adult gata2aΔi4/Δi4 mutants. To
investigate whether Gata2a plays a role in adult haematopoiesis,
we ﬁrst asked whether the gata2a-i4-1.1 kb:GFP reporter was
active in haematopoietic cells in the adult. Whole kidney marrow
(WKM) cells isolated from the transgenic ﬁsh showed that the i4
enhancer is active in haematopoietic cells previously deﬁned by
ﬂow cytometry41 as progenitors, lymphoid+HSPC (containing
the HSPCs) and myeloid cells (Supplementary Fig. 6a–c).
Accordingly, single cell transcriptional proﬁling showed higher
levels of gata2a in HSPCs, progenitors, neutrophils and throm-
bocytes (Supplementary Fig. 6d–f)42,43. Consistent with this
notion, we observed a high incidence of infections and heart
oedemas in gata2aΔi4/Δi4 adult ﬁsh, with over 25% suffering from
one of these defects by 6 months of age, compared to <1% of
wild-type ﬁsh (Fig. 6a–c). The heart oedemas and the infections
are suggestive of lymphatic defects and immune deﬁciency as
observed in human patients bearing genetic GATA2 hap-
loinsufﬁciency syndromes such as MonoMAC syndrome13.
Notably, around 10% of MonoMAC syndrome patients show
mutations in the homologous enhancer region of GATA212,14.
Next, we counted the total number of haematopoietic cells in
wild-type and gata2aΔi4/Δi4 mutant WKM (Fig. 6d–f). To avoid
any confounding effects in our analysis, we compared wild-type
to gata2aΔi4/Δi4 mutants without overt signs of infection. The
gata2aΔi4/Δi4 mutants showed a ~2-fold decrease in the total
number of haematopoietic cells in the WKM (Fig. 6d–f). In
Fig. 5 Gata2b and Notch signalling are sufﬁcient to recover haematopoietic markers in gata2aΔi4/Δi4 mutants. a Expression of runx1 in HE at 32hpf in
wild-type (wt), gata2b MO-injected (7.5 ng) wt embryos, gata2aΔi4/Δi4 mutants and gata2b MO-injected (7.5 ng) gata2aΔi4/Δi4 mutants. b Quantiﬁcation
of the runx1 in situ hybridization (ISH) signal in wt, gata2b morphants, gata2aΔi4/Δi4 mutants and gata2aΔi4/Δi4 mutants injected with gata2b MO. runx1
expression is decreased in gata2aΔi4/Δi4 mutants (µwt= 41.9, µmut= 28.9; F= 44.641, d.f.= 3, 62.3; p < 0.001). Gata2b MO knockdown signiﬁcantly
decreases runx1 in the DA of gata2aΔi4/Δi4mutants (µmut= 28.9, µmut+MO= 17.2), but not wt embryos at 32hpf (µwt= 41.9, µMO= 40.1; p= 0.89, p=
0.89, Games-Howell post-hoc test, Welch’s ANOVA). n= 27, wt; n= 27, gata2aΔi4/Δi4; n= 33, wt + gata2b MO; n= 32, gata2aΔi4/Δi4+ gata2b MO.
c Scoring cmyb expression at 4dpf in wt, gata2aΔi4/Δi4 mutants and gata2aΔi4/Δi4 mutant embryos injected with gata2b MO as wt (blue) or reduced (red).
Gata2b MO knockdown (7.5 ng) inhibits the haematopoietic recovery of gata2aΔi4/Δi4 mutants. (Χ2= 18.784, d.f.= 2, p < 0.001). d Quantiﬁcation of the
runx1 ISH signal, from 28hpf wt embryos (blue), gata2aΔi4/Δi4 mutants (red) and their siblings injected with a gata2a-i4-450bp:gata2b construct (shaded
blue and red). Ectopic expression of gata2b increases runx1 expression in the HE of wt embryos (µwt= 38.8, µwt+gata2b= 53.4; p < 0.01) and rescues runx1
expression in the DA of gata2aΔi4/Δi4 mutants to wt levels (µmut= 17.9, µmut+gata2b= 33.2; p < 0.001; µwt= 38.8, µmut+gata2b= 33.2; p= 0.31, Tukey HSD
post-hoc test). n= 25, wt; n= 33, gata2aΔi4/Δi4;n= 18, wt+ gata2a-i4-450bp:gata2b construct; n= 17, gata2aΔi4/Δi4+ gata2a-i4-450bp:gata2b construct.
e Quantiﬁcation of the runx1 ISH signal at 36hpf in embryos treated with a suboptimal dose (25 μM) of the Notch inhibitor DAPM. 25 μM DAPM showed
no effect on runx1 expression in wt compared to DMSO-treated embryos (µDMSO= 40.5, µDAPM= 38; p= 0.735, Tukey HSD post-hoc test). DMSO-treated
gata2aΔi4/Δi4 mutants show a decrease in runx1 expression (µDMSO= 40.5, µmut+DMSO= 31.5; F= 25.774, d.f.= 3, 91; ANOVA). DAPM treatment
signiﬁcantly reduced runx1 expression in the DA gata2aΔi4/Δi4 mutants (µmut+DMSO= 31.5, µmut+DAPM= 19.4). n= 27, wt +DMSO; n= 20, gata2aΔi4/Δi4
+DMSO; n= 30, wt+DAPM; n= 20, gata2aΔi4/Δi4+DAPM. f Representative images of the average runx1 expression at 36hpf in wt and gata2aΔi4/Δi4
mutants treated with 25 μM DAPM. Error bars: mean ± SD. **p < 0.01; ***p < 0.001. See also Supplementary Fig. 5.
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addition, neutrophils were similarly reduced (Fig. 6g), another
characteristic in common with MonoMAC syndrome patients14.
Lastly, kidney marrow smears of ten 9-month old gata2aΔi4/Δi4
mutants were assessed. One of the ten mutants showed an excess
of immature myeloid blast cells in the WKM (>98%) and only
minor erythrocyte differentiation (Fig. 6h, i). The presence of
excess blasts is usually an indication of AML in humans. Together
these data strongly suggest that the i4 enhancer is a critical driver
of gata2a expression in adult haematopoietic cells. The enhancer
deletion in gata2aΔi4/Δi4 mutants leads to a hypocellular WKM
and neutropenia, strongly suggestive of marrow failure, a
hallmark of disease progression in Gata2 deﬁciency syndromes.
Discussion
The sub-functionalisation of the Gata2 paralogues in zebraﬁsh
provided an opportunity to unpick the different roles of Gata2 in
the multi-step process of deﬁnitive haematopoiesis. Here we have
investigated the conservation of the Gata2 +9.5 enhancer and
identiﬁed a homologous region in intron 4 of the zebraﬁsh gata2a
locus (gata2a-i4) that is not present in the gata2b locus. The
zebraﬁsh gata2a-i4 enhancer, like the mouse enhancer18, is
sufﬁcient to drive pan-endothelial expression of GFP and
necessary for endothelial expression of gata2a (Figs. 1 and 2). We
traced the activity of the i4 enhancer back to the PLM, the source
of precursors of endothelium and HSCs10. This degree of
sequence and functional conservation of the i4 enhancer led us to
hypothesize that Gata2a might play a role in deﬁnitive haema-
topoiesis. Indeed, homozygous deletion of the i4 enhancer
(gata2aΔi4/Δi4) allowed us to uncover a previously unknown
function of Gata2a in regulating the initial expression of runx1
and gata2b in HE. Although cmyb expression in HE was
decreased in gata2aΔi4/Δi4 mutants, it was more severely reduced
in gata2b−/− mutants, suggesting that Gata2b is more important
for cmyb regulation than Gata2a. However, both Gata2 ortholo-
gues regulate gene expression in the HE before the ﬁrst reported
EHT events at 34hpf6.
Gata2 binds to the +9.5 enhancer to maintain its own
expression in endothelial and haematopoietic cells26,44. In zeb-
raﬁsh, it is likely that Gata2a binds the GATA motifs in the i4
enhancer and loss of gata2a in the endothelium of gata2aΔi4/Δi4
mutants (Fig. 2) seems to support this view. Interestingly, we
detected a small region in intron 4 of the gata2b locus that was
Fig. 6 Gata2aΔi4/Δi4 mutants show cardiac oedema, hypocellularity and marrow failure. a, b General morphology of zebraﬁsh adults: a wild-type;
b gata2aΔi4/Δi4 mutant showing skin infection (blue arrowhead) and pericardial oedema (yellow arrowhead). c Over 25% (n= 29/108) of gata2aΔi4/Δi4
mutants (red) catch infections or suffer from heart oedemas by 6 months. Only around 65% (n= 69/108) survive for more than 12 months without overt
signs of infections. Fewer than 1% (n= 2/500) of wild-type ﬁsh (blue) exhibit such defects. The graph does not include deaths by other causes. d, e May-
Grunwald/Wright-Giemsa staining in cytospins of haematopoietic cells isolated from the WKM of zebraﬁsh adults: d wild-type; e gata2aΔi4/Δi4 mutant.
Note the decrease in cell numbers. f Cell counts of haematopoietic cells isolated from WKM of wild-type (n= 14) and gata2aΔi4/Δi4 mutants (n= 8). The
gata2aΔi4/Δi4 mutants show a ~2-fold decrease in haematopoietic cell numbers in the WKM (μwt= 4.37 × 105; μmut= 2.37 × 105, p= 0.0185, Mann-
Whitney test). (g) Number of neutrophils isolated from WKM of wild-type (n= 14) and gata2aΔi4/Δi4 mutants (n= 7). The gata2aΔi4/Δi4 mutants show a
~2-fold decrease in neutrophil numbers in the WKM (μwt= 2.17 × 105; μmut= 1.03 × 105, p= 0.0269, Mann-Whitney test). Error bars: median cell number
± SD. h, i Kidney smears from 9 months post-fertilization adult animals were assessed. hWild-type shows various stages of lineage differentiation. iWKM
smear; 1 of 10 gata2aΔi4/Δi4 mutants showed the presence of excess blasts with very little erythroid differentiation (98% blasts, >200 cells assessed).
Scalebars: 2 mm (a, b) and 10 μm (d, e, h, i). See also Supplementary Fig.6.
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not identiﬁed as a peak in our ATACseq experiment but is
conserved in some ﬁsh species (Supplementary Fig. 1a) and thus
could potentially represent a divergent gata2b intronic enhancer.
We speculate that the positive autoregulation of Gata2 was likely
retained by both gata2 orthologues in zebraﬁsh, but this possi-
bility remains to be investigated.
The gata2aΔi4/Δi4 mutants recovered from the early defects in
HE programming and displayed normal expression levels of cmyb
in the CHT at 4dpf and rag1 in the thymus at 5dpf, used as
indicators of the deﬁnitive haematopoietic programme11. We
hypothesized that this could be due to the presence of the two
homologues of Gata2 in zebraﬁsh20, despite Gata2a and Gata2b
proteins being only 50% identical21. Indeed, forced expression of
gata2b under the gata2a-i4 enhancer rescued DA expression of
runx1 in the gata2aΔi4/Δi4 mutants to wild-type levels and sub-
optimal depletion of gata2b in the gata2aΔi4/Δi4 mutants resulted
in more severe reduction in cmyb expression in the CHT by 4dpf
(Fig. 4). In addition, we demonstrated that Notch signalling, a
known regulator of gata2b expression21, is sufﬁcient to rescue the
initial HE programming defect induced by deletion of the gata2a-
i4 enhancer. We propose a model in which gata2a acts upstream
of runx1 and gata2b independently of Notch to initiate HE
programming. The regulation of gata2b by Gata2a is transient,
and the timing largely coincides with the natural decrease in
endothelial expression of gata2a by 30hpf. After this stage,
endothelial Notch signalling takes over the regulation of runx1
and gata2b expression, acting as a fail-safe mechanism that buf-
fers against ﬂuctuations in the system caused by loss of one or
more of the initial inputs (in this case, Gata2a).
Despite the apparent haematopoietic recovery, we observed a
high incidence of infections and oedema in gata2aΔi4/Δi4 adults,
and a striking decrease in the number of haematopoietic cells in
the WKM. The decrease in haematopoietic cells in particular is
reminiscent of the loss of proliferative potential of haematopoietic
Gata2+/− heterozygous cells in the mouse17,45. This raises the
possibility that in zebraﬁsh the gata2a and gata2b paralogues may
function as two Gata2 ‘alleles’ that together regulate the haema-
topoietic output of the WKM. This will be addressed by com-
paring the adult phenotypes of gata2aΔi4/Δi4 and gata2b−/−
mutants.
Taken together, our initial characterization of WKM shows
that gata2aΔi4/Δi4 mutants present a phenotype consistent with
Gata2 deﬁciency syndromes in humans brought about by GATA2
haploinsufﬁciency12,26. Strikingly, about 10% of all MonoMAC
patients show mutations in the conserved +9.5 enhancer12,14, the
corresponding regulatory element to the i4 enhancer. The i4
enhancer is active in the lymphoid+HSPC fraction that contains
the HSC activity46, in the progenitor cells and in the myeloid
fraction that contains eosinophils, previously identiﬁed as
expressing high levels of a gata2a-GFP BAC transgenic repor-
ter41. Thus, it is likely that gata2aΔi4/Δi4 adult ﬁsh show lineage-
speciﬁc differentiation defects. Further characterization of the
gata2aΔi4/Δi4 mutants will uncover which haematopoietic cells are
most affected by the loss of i4 enhancer activity and how Gata2a
regulates haematopoietic output, thus establishing a zebraﬁsh
animal model for human diseases linked to Gata2
haploinsufﬁciency.
Methods
Maintenance of zebraﬁsh. Zebraﬁsh (Danio rerio) were maintained in ﬂowing
system water at 28.5 °C, conductance 450–550 μS and pH 7.0 ± 0.5 as described47.
Fish suffering from infections or heart oedemas were culled according to Schedule 1
of the Animals (Scientiﬁc Procedures) Act 1986. Eggs were collected by natural
mating. Embryos were grown at 24–32 °C in E3 medium with methylene blue and
staged according to morphological features corresponding to respective age in hours
or days post-fertilization (hpf or dpf, respectively). Published strains used in this
work were wild-type (wtKCL), Tg(−6.0itga2b:EGFP)la2 38,48 and Tg(kdrl:GFP)s843 28;
animals were used at embryonic and larval stages and as adults (male and female) as
speciﬁed in the ﬁgures. All animal experiments were approved by the relevant
University of Oxford, University of Birmingham and Erasmus University ethics
committees.
ATAC-seq. Tg(kdrl:GFP)s843 embryos were dissociated for FACS at 26-27hpf to
collect kdrl+ and kdrl− cell populations (40,000–50,000 cells each). They were
processed for ATAC library preparation using optimised standard protocol27.
Brieﬂy, after sorting into Hanks’ solution (1xHBSS, 0.25% BSA, 10 mM HEPES
pH8), the cells were spun down at 500 g at 4 °C, washed with ice-cold PBS and
resuspended in 50 µl cold Lysis Buffer (10 mM Tris-HCl, 10 mM NaCl, 3 mM
MgCl2, 0.1% IGEPAL, pH 7.4). The nuclei were pelleted for 10 min. at 500 × g at 4 °
C and resuspended in the TD Buffer with Tn5 Transposase (Illumina), scaling the
amounts of reagents accordingly to the number of sorted cells. The transposition
reaction lasted 30 min. at 37 °C. The DNA was puriﬁed with PCR Puriﬁcation
MinElute Kit (QIAGEN). In parallel, transposase-untreated genomic DNA from
kdrl+ cells was puriﬁed with the DNeasy® Blood & Tissue Kit (QIAGEN). The
samples were ampliﬁed with appropriate Customized Nextera primers27 in NEB-
Next High-Fidelity 2x PCR Master Mix (NEB). The libraries were puriﬁed with
PCR Puriﬁcation MinElute Kit (QIAGEN) and Agencourt AMPure XP beads
(Beckmann Coulter). The quality of each library was veriﬁed using D1000
ScreenTape System (Agilent). Four biological replicas of the libraries were quan-
tiﬁed with the KAPA Library Quantiﬁcation Kit for Illumina® platforms (KAPA
Biosystems). The libraries were pooled (including the Tn5-untreated control),
diluted to 1 ng/µl and sequenced using 75 bp paired-end reads on Illumina HiSeq
4000 (Wellcome Trust Centre for Human Genetics, Oxford). Raw sequenced reads
were checked for base qualities, trimmed where 20% of the bases were below
quality score 20, and ﬁltered to exclude adapters using Trimmomatic (Version 0.32)
and mapped to Zv9 reference genome (comprising 14,612 genes)49 using BWA
with default parameters. The results were visualised using UCSC Genome Browser
(http://genome-euro.ucsc.edu/)50. The eight data sets were analysed with Principal
Component Analysis (PCA) to identify outliers. Correlation among kdrl:GFP+ and
kdrl:GFP− samples was assessed with a tree map. The peaks were called for each
sample using the Tn5-untreated control as input. We identiﬁed the common peaks
between replicates and then used DiffBind (EdgeR method) to identify differential
peaks between kdrl:GFP+ and kdrl:GFP−samples (Supplementary Data 2). The
threshold for differential peaks was p < 0.05.
Generation of transgenic and mutant zebraﬁsh lines. Genomic regions con-
taining the identiﬁed 150bp-long gata2a-i4 enhancer ﬂanked by ±500 bp (i4–1.1
kb) or ±150 bp (i4–450bp) were ampliﬁed from wild-type zebraﬁsh genomic DNA
with NEB Phusion® polymerase (see Supplementary Table 1 for primer sequences)
and cloned upstream of E1b minimal promoter and GFP into a Tol2 recombina-
tion vector (Addgene plasmid #3784551) with Gateway® cloning technology (Life
Technologies™) following the manufacturer’s protocol. One-cell zebraﬁsh embryos
were injected with 1 nl of an injection mix, containing 50 pg gata2a-i4-E1b-GFP-
Tol2 construct DNA+ 30 pg tol2 transposase mRNA31. Transgenic founders (Tg
(gata2a-i4-1.1 kb:GFP) and (gata2a-i4-450 bp:GFP)) were selected under a wide-
ﬁeld ﬂuorescent microscope and outbred to wild-type ﬁsh. Carriers of monoallelic
insertions were detected by the Mendelian distribution of 50% ﬂuorescent offspring
coming from wild-type outcrosses. These transgenics were then inbred to
homozygosity.
To generate the i4 deletion mutant, we identiﬁed potential sgRNA target sites
ﬂanking the 150 bp conserved region within intron 4 of the gata2a locus (see
Fig. 1a, Supplementary Fig 3a). sgRNAs were designed with the CRISPR design tool
(http:/crispr.mit.edu/, see Supplementary Table 1 for sequences) and prepared as
described32. To reduce potential off-target effects of CRISPR/Cas9, we utilized the
D10A ‘nickase’ version of Cas9 nuclease52,53, together with two pairs of sgRNAs
ﬂanking the enhancer (Supplementary Table 1, Supplementary Fig. 3a, b). We
isolated two mutant alleles with deletions of 215 bp (Δ78–292) and 231 bp
(Δ73–303) (Supplementary Fig. 3b). Both deletions included the highly conserved
E-box, Ets and GATA transcription factor binding sites (Supplementary Fig. 3b).
The Δ73–303 allele was selected for further experiments and named Δi4. Adult
zebraﬁsh were viable and fertile as heterozygous (gata2aΔi4/+) or homozygous
(gata2aΔi4/Δi4). To unambiguously genotype wild types, heterozygotes and
homozygous mutants, we designed a strategy consisting of two PCR primer pairs
(Supplementary Fig. 3a, c). One primer pair ﬂanked the whole region, producing a
600 bp wild-type band and 369 bp mutant band. In the second primer pair, one of
the primers was designed to bind within the deleted region, only giving a 367 bp
band in the presence of the wild-type allele (Supplementary Fig. 3c).
To generate the gata2b mutant we designed a CRISPR/Cas9 strategy for a
frameshift truncating mutant in exon 3 deleting both zinc ﬁngers. sgRNAs were
designed as described above and guides were prepared according to Gagnon et al.54
with minor adjustments. Guide RNAs were generated using the Agilent SureGuide
gRNA Synthesis Kit, Cat# 5190–7706. Cas9 protein (IDT) and guide were allowed
to form ribonucleoprotein structures (RNPs) at RT and injected in 1 cell stage
oocytes. 8 embryos were selected at 24 hpf and lysed for DNA isolation.
Heteroduplex PCR analysis was performed to test guide functionality and the other
embryos from the injection were allowed to grow up. To aid future genotyping we
selected mutants by screening F1 for a PCR detectable integration or deletion in
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exon 3. Sequence veriﬁcation showed that founder 3 had a 28 nt integration
resulting in a frameshift truncating mutation leading to 3 new STOP codons in the
third exon. To get rid of additional mutations caused by potential off-target effects,
founder 3 was crossed to WT for at least 3 generations. All experiments were
performed with offspring of founder 3.
Fluorescence-activated cell sorting (FACS). Appoximately 100 embryos at the
required stage were collected in Low Binding® SafeSeal® Microcentrifuge Tubes
(Sorenson) and pre-homogenized by pipetting up and down in 500 µl Deyolking
Buffer (116 mM NaCl, 2.9 mM KCl, 5 mM HEPES, 1 mM EDTA). They were spun
down for 1 min. at 500 g and incubated for 15 min. at 30 °C in Trypsin+ Col-
lagenase Solution (1xHBSS, 0.05% Gibco® Trypsin+ EDTA (Life Technologies™),
20 mg/ml collagenase (Sigma)). During that time, they were homogenized by
pipetting up and down every 3 min. The lysis was stopped by adding 50 µl foetal
bovine serum and 650 µl ﬁlter-sterilized Hanks’ solution (1xHBSS, 0.25% BSA, 10
mM HEPES pH8). The cells were rinsed with 1 ml Hanks’ solution and passed
through a 40 µm cell strainer (Falcon®). They were resuspended in ~400 µl Hanks’
solution with 1:10,000 Hoechst 33258 (Molecular Probes®) and transferred to a 5
ml polystyrene round bottom tube for FACS sorting. The cells were sorted on
FACSAria Fusion sorter by Kevin Clark (MRCWIMM FACS Facility). The gates of
GFP (488–530) and DsRed (561–582) channels were set with reference to samples
derived from non-transgenic embryos. The ﬂuorescence readouts were compen-
sated when necessary. For ATAC-seq library preparation, the cells were sorted into
Hank’s solution. For RNA isolation, the cells were sorted directly into RLT Plus
buffer (QIAGEN)+ 1% β-mercaptoethanol and processed with the RNEasy®
Micro Plus kit (QIAGEN), according to the accompanying protocol. The RNA was
quantiﬁed and its quality assessed with the use of Agilent RNA 6000 Pico kit. All
RNA samples were stored at −80 °C.
SYBR® Green qRT-PCR. 3 µl of the cDNA diluted in H2O were used for technical
triplicate qRT-PCR reactions of 20 µl containing the Fast SYBR® Green Master Mix
(Thermo Fisher Scientiﬁc) and appropriate primer pair (see Supplementary
Table 1). The reactions were run on 7500 Fast Real-Time PCR System (Applied
Biosystems) and the results were analysed with the accompanying software. No-
template controls were run on each plate for each primer pair. Each reaction was
validated with the melt curve analysis. The baseline values were calculated auto-
matically for each reaction. The threshold values were manually set to be equal for
all the reactions run on one plate, within the linear phase of exponential ampli-
ﬁcation. The relative mRNA levels in each sample were calculated by subtracting
the geometric mean of Ct values for housekeeping genes eef1a1l1 and ubc from the
average Ct values of the technical triplicates for each gene of interest. This value
(ΔCt) was then converted to a ratio relative to the housekeeping genes with the
formula 2−ΔCt.
Fluidigm Biomark qRT-PCR. To quantify the differences in gata2a expression
between wild-type and mutant ECs, we crossed homozygous gata2aΔi4/Δi4 mutants
to Tg(kdrl:GFP) transgenics to generate Tg(kdrl:GFP); gata2aΔi4/Δi4 embryos.
These ﬁsh, along with non-mutant Tg(kdrl:GFP), were used for FACS-mediated
isolation of kdrl:GFP+ and kdrl:GFP− cells to quantitatively compare mRNA
expression levels of gata2a in the endothelial and non-endothelial cells of wild-type
and gata2aΔi4/Δi4 embryos, using the Fluidigm Biomark™ qRT-PCR platform.
Brieﬂy, 1 ng RNA from FACS-sorted cells was used for Speciﬁc Target Ampliﬁ-
cation in a 10 µl reaction with the following reagents: 5 µl 2xBuffer and 1.2 µl
enzyme mix from SuperScript III One-Step Kit (Thermo Fisher Scientiﬁc), 0.1 µl
SUPERase• In™ RNase Inhibitor (Ambion), 1.2 µl TE buffer (Invitrogen), 2.5 µl 0.2x
TaqMan® assay mix (see Supplementary Table 2 for the details of TaqMan®
assays). The reaction was incubated for 15 min. at 50 °C, for 2 min. at 95 °C and
ampliﬁed for 20 cycles of 15 s at 95 °C/4 min. at 60 °C. The cDNA was diluted 1:5
in TE buffer and stored at −20 °C. Diluted cDNA was used for qRT-PCR according
to the Fluidigm protocol for Gene Expression with the 48.48 IFC Using Standard
TaqMan® Assays (Supplementary Table 2). Each sample was run in 3–4 biological
replicates. The collected data were analysed with Fluidigm Real-Time PCR Analysis
software (version 4.1.3). The baseline was automatically corrected using the built-in
Linear Baseline Correction. The thresholds were manually adjusted for each gene to
fall within the linear phase of exponential ampliﬁcation, after which they were set
to equal values for the housekeeping genes: rplp0, rpl13a, cops255, lsm12b56 and
eef1a1l1. The relative mRNA levels for each sample were calculated by subtracting
the geometric mean of Ct values for the housekeeping genes from the Ct value for
each gene of interest. This value (ΔCt) was then converted to a ratio relative to the
housekeeping genes with the formula 2−ΔCt. The ΔCt values were analysed with 2-
tailed paired-samples t-tests with 95% conﬁdence levels.
Flow cytometry and isolation of WKM haematopoietic cells. Single cell sus-
pensions of WKM cells were prepared from adult zebraﬁsh kidneys of the required
genotypes as described57. Brieﬂy, adult zebraﬁsh were ﬁrst euthanized in 0.5%
tricaine in PBS and dissected to remove the kidney. WKM cells were recovered by
vigorous pipetting in 0.5 ml PBS with 10% Foetal Calf Serum (PBS+ 10%FCS),
followed by ﬁltration in a cell strainer (FALCON, ref 352235) pre-coated with PBS
+ 10%FCS. Strainers were rinsed with PBS+ 10%FCS and the cells spun down
(~300 g, 10 min at 4 °C) and ressuspended in 200–500 μl PBS+ 10%FCS with
Hoechst 33342 1:10000 (Hoechst 33342, H3570, ThermoScientiﬁc). Flow cyto-
metry analysis was performed on a FACS Aria II (BD Biosciences) after exclusion
of dead cells by uptake of Hoechst dye, as described41. WKM cell counts were
performed on a PENTRA ES60 (Hariba Medical) following the manufacturer’s
instructions. Note that the cell counter does not recognize the zebraﬁsh nucleated
erythrocytes, so these were excluded from this analysis. Cell counts for each gen-
otype were analysed with 2-tailed paired-samples t-tests with 95% conﬁdence
levels, using a Mann-Whitney test for non-parametric distribution. The scatter
plots were generated using GraphPad Prism 8.0 and show medians ± SD.
May-Grunwald and Wright-Giemsa staining. Cell staining with May-Grunwald
(MG) stain (Sigma MG500) and Giemsa (GIEMSA STAIN, FLUKA 48900) was
performed on haematopoietic cell samples. After cytospin, slides are allowed to air-
dry and were stained for 5 min at room temperature with a 1:1 mix of MG:distilled
water. Next, slides were drained and stained with a 1:9 dilution of Giemsa:distilled
water solution for 30 min at room temperature. Excess solution was drained and
removed by further washes in distilled water. Finally, the slides were air-dried and
mounted in DPX (06522, Sigma) for imaging.
Whole-mount in situ hybridization and immunohistochemistry. Whole-mount
in situ hybridization (ISH) was carried out as described previously58, using probes
for kdrl, runx1, cmyb, gata2a, gata2b, rag14,37,59,60 and gfp (Supplementary
Table 1). For conventional ISH embryos were processed, imaged and the ISH signal
quantiﬁed as described34. Brieﬂy, the pixel intensity values were assessed for
normal distribution with a Q-Q plot and transformed when necessary. Mean values
(µ) of each experimental group were analysed with 2-tailed independent-samples t-
tests or with ANOVA with 95% conﬁdence levels, testing for the equality of var-
iances with a Levene’s or Brown-Forsythe test and applying the Welch correction
when necessary. For ANOVA, differences between each two groups were assessed
with either Tukey’s post-hoc test (for equal variances) or with Games-Howell test
(for unequal variances). For all these analyses, the IBM® SPSS® Statistics (version
22) or GraphPad Prism 8.0 package were used.
For the analysis of cmyb expression in the CHT at 4dpf, the embryos scored as
‘high’ or ‘low’ were tested for equal distribution between morphants and uninjected
controls or among wild-type, heterozygous and mutant genotypes with
contingency Chi-squared tests, applying Continuity Correction for 2 × 2 tables,
using IBM® SPSS® Statistics (version 22).
For ﬂuorescent ISH (FISH) combined with immunohistochemistry, ISH was
performed ﬁrst following the general whole-mount in situ hybridisation protocol.
The signal was developed with SIGMAFAST Fast Red TR/Naphthol, the embryos
rinsed in phosphate-buffered saline with tween20 (PBT) and directly processed for
immunohistochemistry. Embryos were blocked in blocking buffer (5% goat serum/
0.3% Triton X-100 in PBT) for 1 h at RT before incubated with primary antibody
against GFP (rabbit, 1:500, Molecular Probes), diluted in blocking buffer overnight
at 4 °C. Secondary antibody raised in goat coupled to AlexaFluor488 (Invitrogen)
was used in 1:500 dilutions for 3 h at RT. Hoechst 33342 was used as a nuclear
counterstain.
Fluorescent images were taken on a Zeiss LSM880 confocal microscope using
×40 or ×63 oil immersion objectives. Images were processed using the ZEN
software (Zeiss).
Fluorescence microscopy and cell counting. For wideﬁeld ﬂuorescence micro-
scopy, live embryos were anaesthetised with 160 μg/ml MS222 and mounted in 3%
methylcellulose and imaged on a AxioLumar V.12 stereomicroscope (Zeiss)
equipped with a Zeiss AxioCam MrM. To count itga2b-GFPhigh and itga2b-GFPlow
cells in the CHT, Tg(itga2b:GFP;kdrl:mCherry); gata2aΔi4/+ animals were incros-
sed and grown in E3 medium supplemented with PTU to prevent pigment for-
mation. At 5dpf, the larvae were anaesthetised with MS222 and the tail was cut and
ﬁxed for 1 h at room temperature in 4% PFA. Next, the tails were mounted on 35
mm glass bottomed dishes (MAtTEK) in 1% low melt agarose and imaged using a
×40 oil objective on an LSM880 confocal microscope (Zeiss). Cells in the CHT
region were counted manually on Z-stacks as ‘itga2b:GFPlow’ (HSPCs) or ‘itga2b:
GFPhigh’ (thrombocytes). Genomic DNA from the heads was extracted and used
for genotyping as described above. Cell counts for each genotype were analysed
with 2-tailed paired-samples t-tests with 95% conﬁdence levels, using a Mann-
Whitney test for non-parametric distribution. The graphs were generated using
GraphPad Prism 8.3.0 and show medians ± SD.
Statistics and reproducibility. Data were analysed using either IBM® SPSS®
Statistics (version 22) or GraphPad Prism software (v8.02). In situ quantiﬁcation
data was analysed with 2-tailed independent-samples t-tests or with ANOVA with
95% conﬁdence levels, testing for the equality of variances with a Levene’s or
Brown-Forsythe test and applying the Welch correction when necessary. For
ANOVA, differences between each two groups were assessed with either Tukey’s
post-hoc test (for equal variances) or with Games-Howell test (for unequal var-
iances). Alternatively, data were analysed with an appropriate non-parametric test
(Kruskall-Wallis) followed by Dunn’s multiple comparisons test or uncorrected
Dunn’s test where appropriate. Cell count data were analysed with 2-tailed paired-
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samples t-tests with 95% conﬁdence levels, using a Mann-Whitney test for non-
parametric distribution. Gene expression data were analysed with 2-tailed paired-
samples t-tests with 95% conﬁdence levels.
All experiments were repeated at least three times with similar results obtained;
sample sizes are shown in the respective ﬁgure legends.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All data generated or analyzed during this study (images, quantitation data in the form of
graphs and ATACseq data) are included in this published article and its supplementary
information ﬁles. The source data are available in Supplementary Data 1 and the list of
the called ATACseq peaks is available in Supplementary Data 2. The ATACseq data was
deposited in GEO (Accession number GSE143763).
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